Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
el-Ghoroury
M
M
Department of Internal Medicine, University of Cincinnati Medical Center, Ohio, USA.
Hariharan
S
S
Munda
R
R
Demmy
A M
AM
Schroeder
T J
TJ
Alexander
J W
JW
First
M R
MR
D000208:Acute Disease; D000328:Adult; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000009:adverse effects*; D012189:Retrospective Studies
D016853:Muromonab-CD3; D003404:Creatinine; D008775:Methylprednisolone